Park J - Search Results

1

Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities.

Lee EJ, Sung JY, Koo KH, Park JB, Kim DH, Shim J, Lee CH, Park J, Kim YN. Lee EJ, et al. Among authors: park jb, park j. Int J Mol Sci. 2020 Nov 26;21(23):8982. doi: 10.3390/ijms21238982. Int J Mol Sci. 2020. PMID: 33256086 Free PMC article.

2

HIF-1 is induced via EGFR activation and mediates resistance to anoikis-like cell death under lipid rafts/caveolae-disrupting stress.

Lee SH, Koo KH, Park JW, Kim HJ, Ye SK, Park JB, Park BK, Kim YN. Lee SH, et al. Carcinogenesis. 2009 Dec;30(12):1997-2004. doi: 10.1093/carcin/bgp233. Carcinogenesis. 2009. PMID: 19789263

3

Molecular mechanism of HIF-1-independent VEGF expression in a hepatocellular carcinoma cell line.

Choi SB, Park JB, Song TJ, Choi SY. Choi SB, et al. Int J Mol Med. 2011 Sep;28(3):449-54. doi: 10.3892/ijmm.2011.719. Epub 2011 Jun 8. Int J Mol Med. 2011. PMID: 21667015

4

Preclinical development of a humanized neutralizing antibody targeting HGF.

Kim H, Hong SH, Kim JY, Kim IC, Park YW, Lee SJ, Song SW, Kim JJ, Park G, Kim TM, Kim YH, Park JB, Chung J, Kim IH. Kim H, et al. Among authors: park yw, park jb, park g. Exp Mol Med. 2017 Mar 24;49(3):e309. doi: 10.1038/emm.2017.21. Exp Mol Med. 2017. PMID: 28336956 Free PMC article.

5

An anti-EGFR × cotinine bispecific antibody complexed with cotinine-conjugated duocarmycin inhibits growth of EGFR-positive cancer cells with KRAS mutations.

Jin J, Park G, Park JB, Kim S, Kim H, Chung J. Jin J, et al. Among authors: park jb, park g. Exp Mol Med. 2018 May 24;50(5):1-14. doi: 10.1038/s12276-018-0096-z. Exp Mol Med. 2018. PMID: 29795377 Free PMC article.

6

Nogo receptor-vimentin interaction: a novel mechanism for the invasive activity of glioblastoma multiforme.

Kang YH, Han SR, Jeon H, Lee S, Lee J, Yoo SM, Park JB, Park MJ, Kim JT, Lee HG, Lee MS, Lee SH. Kang YH, et al. Among authors: park mj, park jb. Exp Mol Med. 2019 Oct 24;51(10):1-15. doi: 10.1038/s12276-019-0332-1. Exp Mol Med. 2019. PMID: 31649250 Free PMC article.

7

STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model.

Kim BH, Lee H, Park CG, Jeong AJ, Lee SH, Noh KH, Park JB, Lee CG, Paek SH, Kim H, Ye SK. Kim BH, et al. Cells. 2020 Mar 15;9(3):722. doi: 10.3390/cells9030722. Cells. 2020. PMID: 32183406 Free PMC article.

8

ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages.

Yin J, Kim SS, Choi E, Oh YT, Lin W, Kim TH, Sa JK, Hong JH, Park SH, Kwon HJ, Jin X, You Y, Kim JH, Kim H, Son J, Lee J, Nam DH, Choi KS, Shi B, Gwak HS, Yoo H, Iavarone A, Kim JH, Park JB. Yin J, et al. Among authors: park jb, park sh. Nat Commun. 2020 Jun 12;11(1):2978. doi: 10.1038/s41467-020-16789-2. Nat Commun. 2020. PMID: 32532977 Free PMC article.

9

Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastoma.

Kim S, Park SJ, Chowdhury T, Hong JI, Ahn J, Jeong TY, Yu HJ, Shin YK, Ku JL, Park JB, Hur JK, Lee H, Kim K, Park CK. Kim S, et al. Among authors: park jb, park ck, park sj. Cell Mol Life Sci. 2022 Mar 12;79(3):181. doi: 10.1007/s00018-022-04188-3. Cell Mol Life Sci. 2022. PMID: 35278143 Free PMC article.

10

Extracellular Vesicles from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients Deliver MiR-21 and Induce Methotrexate Resistance in Lung Cancer Cells.

Im JH, Lee KY, Seo Y, Rhim J, Dho YS, Yoo BC, Park JB, Shin SH, Yoo H, Kim JH, Gwak HS. Im JH, et al. Among authors: park jb. Int J Mol Sci. 2024 Mar 8;25(6):3124. doi: 10.3390/ijms25063124. Int J Mol Sci. 2024. PMID: 38542098 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68,336 results

Search Page